Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

Carl Icahn rattled the health care industry on Wednesday. Icahn, an activist investor, built a sizable stake in health insurer Cigna, the Wall Street Journal reported. Cigna is in the process of ...

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts has earned a respected ...

Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's ...

Cigna’s stock price dropped March 8 after the company announced a $67 billion deal to acquire pharmacy benefits manager Express Scripts. Cigna’s stock price was down 11.46 percent at market close ...

ST. LOUIS -- Shares of Express Scripts Inc., among the nation's largest pharmacy benefit managers, extended their 52-week high on Friday, courtesy of its expectations of a better-than-expected first ...

Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...

June 19 (Reuters) - UBS downgraded two major U.S. pharmacy benefit managers, saying potential benefits from the launch of a generic version of Pfizer Inc's blockbuster cholesterol drug Lipitor were ...

Express Scripts director Dr. Woodrow Myers Jr. exercised stock options for 7,128 shares worth $30.83. Myers sold those shares for $64.66 on Sept. 4, which earned him $241,140 after paying to exercise ...

NEW YORK (Reuters) - Express Scripts Inc. on Tuesday launched a $24.8 billion offer for Caremark Rx Inc. , the latest step in a high-stakes takeover battle after Caremark last week said it preferred a ...